A subset of dysregulated metabolic and survival genes is associated with severity of hepatic steatosis in obese Zucker rats.
We aimed to characterize the primary abnormalities associated with fat accumulation and vulnerability to hepatocellular injury of obesity-related fatty liver. We performed functional analyses and comparative transcriptomics of isolated primary hepatocytes from livers of obese insulin-resistant Zucker rats (comprising mild to severe hepatic steatosis) and age-matched lean littermates, searching for novel genes linked to chronic hepatic steatosis. Of the tested genome, 1.6% was identified as steatosis linked. Overexpressed genes were mainly dedicated to primary metabolism (100%), signaling, and defense/acute phase (approximately 70%); detoxification, steroid, and sulfur metabolism (approximately 65%) as well as cell growth/proliferation and protein synthesis/transformation (approximately 70%) genes were downregulated. The overexpression of key genes involved in de novo lipogenesis, fatty acid and glycerolipid import and synthesis, as well as acetyl-CoA and cofactor provision was paralleled by enhanced hepatic lipogenesis and production of large triacylglycerol-rich VLDL. Greatest changes in gene expression were seen in those encoding the lipogenic malic enzyme (up to 7-fold increased) and cell-to-cell interacting cadherin 17 (up to 8-fold decreased). Among validated genes, fatty acid synthase, stearoyl-CoA desaturase 1, fatty acid translocase/Cd36, malic enzyme, cholesterol-7 alpha hydroxylase, cadherin 17, and peroxisome proliferator-activated receptor alpha significantly correlated with severity of hepatic steatosis. In conclusion, dysregulated expression of metabolic and survival genes accompany hepatic steatosis in obese insulin-resistant rats and may render steatotic hepatocytes more vulnerable to cell injury in progressive nonalcoholic fatty liver disease.
Department of Physiology, University of the Basque Country Medical School, Bilbao, Spain.
Xabier
X
Buqué
María José
MJ
Martínez
Ainara
A
Cano
María E
ME
Miquilena-Colina
Carmelo
C
García-Monzón
Patricia
P
Aspichueta
Begoña
B
Ochoa
D000818:Animals; D049109:Cell Proliferation; D002470:Cell Survival / Q000235:genetics; D050171:Dyslipidemias / Q000150:complications; D005234:Fatty Liver / Q000150:complications / Q000235:genetics* / Q000378:metabolism* / Q000473:pathology; D020869:Gene Expression Profiling; D007333:Insulin Resistance; D050155:Lipogenesis / Q000235:genetics; D008079:Lipoproteins, VLDL / Q000378:metabolism; D008099:Liver / Q000378:metabolism* / Q000473:pathology; D008297:Male; D009765:Obesity / Q000150:complications*; D051381:Rats; D011924:Rats, Zucker; D013256:Steroids / Q000378:metabolism; D014280:Triglycerides / Q000378:metabolism
D008079:Lipoproteins, VLDL; D013256:Steroids; D014280:Triglycerides